pd 169316 has been researched along with dactinomycin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, A; Hatakeyama, D; Hirade, K; Hotta, K; Ito, H; Kanamori, Y; Katayama, M; Kato, K; Kozawa, O; Matsuno, H; Mori, H; Niwa, M; Uematsu, T | 1 |
| Agostinis, P; de Witte, P; Hendrickx, N; Moens, U; Piette, J; Seternes, OM; Vandenheede, JR; Volanti, C | 1 |
| Guo, QL; Song, ZB; Wu, H; Yan, JQ; Yang, Y | 1 |
| Cao, L; Jiang, X; Tan, R; Xun, J | 1 |
4 other study(ies) available for pd 169316 and dactinomycin
| Article | Year |
|---|---|
Involvement of p38 mitogen-activated protein kinase in heat shock protein 27 induction in human neutrophils.
Topics: Apoptosis; Calcium-Calmodulin-Dependent Protein Kinases; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Enzyme Induction; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation; Heat-Shock Proteins; Humans; Imidazoles; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neutrophils; Nucleic Acid Synthesis Inhibitors; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C; Protein Synthesis Inhibitors; Pyridines; Pyrrolidines; RNA, Messenger; Thiocarbamates; Time Factors; Tumor Necrosis Factor-alpha | 2003 |
Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells.
Topics: Anthracenes; Apoptosis; Blotting, Western; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2; Dactinomycin; Dinoprostone; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; HeLa Cells; Humans; Imidazoles; Isoenzymes; Membrane Proteins; Mitogen-Activated Protein Kinases; Mutation; NF-kappa B; Nitrobenzenes; p38 Mitogen-Activated Protein Kinases; Perylene; Photochemotherapy; Precipitin Tests; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Signal Transduction; Sulfonamides; Time Factors; Transcription, Genetic; Transfection; Up-Regulation | 2003 |
Tumor necrosis factor-α inhibits angiotensin II receptor type 1 expression in dorsal root ganglion neurons via β-catenin signaling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; beta Catenin; Chromans; Dactinomycin; Dose-Response Relationship, Drug; Ganglia, Spinal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Imidazoles; Indoles; Male; Neurons; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Quinazolines; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha | 2013 |
Propofol up-regulates Mas receptor expression in dorsal root ganglion neurons.
Topics: Anesthetics, Intravenous; Angiotensin I; Animals; Blotting, Western; Cells, Cultured; Dactinomycin; Ganglia, Spinal; Imidazoles; Indicators and Reagents; Neurons; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Propofol; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Real-Time Polymerase Chain Reaction; Receptors, G-Protein-Coupled; RNA, Messenger | 2013 |